Practical Approaches to the Genetic Diagnosis and Management of Patients with Diabetes Mellitus
In what patients is genetic testing for diabetes mellitus recommended?
What are the benefits that a genetic diagnosis of diabetes mellitus can offer?
What implications does a genetic diagnosis of diabetes mellitus have on management?
Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline
What are some of the most relevant updates in the new guidelines compared to the previous version?
Why were these updates added?
How can personalized medicine play a role in prevention strategies?
The Impact of COVID-19 on Endocrinology
Are patients with diabetes at higher risk of complications from COVID-19?
What do we know about control of diabetes and the severity of the disease?
What practical tips can you give to healthcare providers managing patients with endocrine diseases in light of the COVID-19 pandemic?
Type 1 Diabetes Mellitus - From Preconception to Postpartum
What are some of the most common misconceptions regarding pregnancy and type 1 diabetes?
How important is planning pregnancy in type 1 diabetes?
How do insulin requirements change during pregnancy and postpartum?
Are there any particular types of insulins to prefer during pregnancy?
Do technologies such as CGM help during pregnancy?
More Than A1c: Important Outcomes for Those with Diabetes
How can successful outcomes be defined in people with diabetes?
Will the use of A1c become obsolete as technologies such as CGM become available?
What metrics are used to measure time-in-range and glucose variability?
Are technologies such as CGM applicable to both T1D and T2D?
What are some of the barriers to the use of CGM?
Beta Cells in Type 1 Diabetes – Sleeping or Dead?
What new insights are being discovered regarding the role of beta cells in type 1 diabetes?
What therapies are being investigated that target beta cells in patients with type 1 diabetes?
How far are we from using therapies that target dysfunctional beta cells in clinical practice?